CCK-B antagonists in the control of anxiety and gastric acid secretion.
Chambers
M S
MS
Neuroscience Research Centre, Merck, Sharp and Dohme Research Laboratories, Harlow, Essex, U.K.
Fletcher
S R
SR
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000188:drug therapy*; D001569:Benzodiazepines; D005744:Gastric Acid / Q000378:metabolism*; D006801:Humans; D009842:Oligopeptides / Q000627:therapeutic use; D043887:Receptor, Cholecystokinin B; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors*
D014151:Anti-Anxiety Agents; D009842:Oligopeptides; D043887:Receptor, Cholecystokinin B; D011949:Receptors, Cholecystokinin; D001569:Benzodiazepines